Yang Liu
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research 126
- MicroRNA in disease regulation 104
- Molecular Biology top 0.1%
- RNA modifications and cancer 105
- Circular RNAs in diseases 78
- Immunology top 0.5%
- Oncology top 0.5%
- Pharmacology top 0.2%
- Microbial Natural Products and Biosynthesis 50
-
- Ferroptosis and cancer prognosis 55
-
- Corneal Surgery and Treatments 49
-
- Ocular Surface and Contact Lens 42
- Co-authors
- Lixia ChenHua LiPeng ZhangCanrong WuYueying YangMengzhu ZhengYali WangYang Xu
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yang Liu
1.8k papers receiving 33.4k citations
Hit Papers
Peers
Comparison fields: 5 of 212
- Cancer Research 6.9k
- Molecular Biology 13.8k
- Immunology 3.2k
- Oncology 3.2k
- Pharmacology 1.8k
Countries citing papers authored by Yang Liu
This map shows the geographic impact of Yang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Liu more than expected).
Fields of papers citing papers by Yang Liu
This network shows the impact of papers produced by Yang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Liu. The network helps show where Yang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 28 | |
| 7 | 2023 | 23 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 26 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 5 | |
| 13 | Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma | 2022 | 6 |
| 14 | 2022 | 7 | |
| 15 | 2021 | 20 | |
| 16 | Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study | 2021 | 1 |
| 17 | 2021 | 4 | |
| 18 | Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p | 2020 | 0 |
| 19 | 2020 | 8 | |
| 20 | Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis | 2020 | 1 |
About Yang Liu
Yang Liu is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 1.9k papers that have together received 33.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (126 papers), RNA modifications and cancer (105 papers), MicroRNA in disease regulation (104 papers), Circular RNAs in diseases (78 papers), Ferroptosis and cancer prognosis (55 papers), Microbial Natural Products and Biosynthesis (50 papers), Corneal Surgery and Treatments (49 papers) and Ocular Surface and Contact Lens (42 papers). The work is most often cited by research in Cancer Research (6.9k citations), Molecular Biology (13.8k citations) and Immunology (3.2k citations). Yang Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Lixia Chen, Hua Li, Peng Zhang, Canrong Wu, Yueying Yang, Mengzhu Zheng, Yali Wang, Yang Xu, Xingzhou Li and Wu Zhong. Their work appears in journals such as Scientific Reports, Medicine, Frontiers in Oncology, Frontiers in Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.